Last $11.83 USD
Change Today +0.76 / 6.87%
Volume 811.3K
BCRX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nancy June Hutson Ph.D.

Director and Chairman of Corporate Governance & Nominating Committee, BioCryst Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 65 board members in 8 different organizations across 7 different industries.

See Board Relationships
65$54,305

Background*

Dr. Nancy June Hutson, Ph.D., served as Senior Vice President of R&D for Groton and New London Campuses at BioCryst Pharmaceuticals, Inc. until March 2006. Dr. Hutson was a Sponsor of the Network of Executive Women, where she served as a mentor for senior women at Pfizer Global Research & Development. She has over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry. She retired from Pfizer, Inc. in 2006 after spending 25 years ...

Read Full Background

Corporate Headquarters*

4505 Emperor Boulevard
Durham, North Carolina 27703

United States

Phone: 919-859-1302
Fax: 919-859-1314

Board Members Memberships*

Trustee
Director
2006-Present
Director, Chairperson of Development Committee and Member of Compensation Committee
2008-Present
Director, Chairman of Corporate Governance & Nominating Committee and Member of Scientific Affairs Committee
2009-Present
Independent Director, Chairman of Operations Committee and Member of Nominating & Governance Committee
2009-Present
Director, Member of Compensation Committee and Member of Transactions Committee
2012-Present
Director and Chairman of Corporate Governance & Nominating Committee

Education*

Doctorate
Vanderbilt University
PhD
Vanderbilt University
BA
Illinois Wesleyan University
Doctorate
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$36,000
Total Calculated Compensation$54,305
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCRX:US $11.83 USD +0.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gustav A. Christensen Chief Executive Officer, President and Director
Dyax Corp.
$615.6K
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€546.0K
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Joji Nakayama President, Chief Executive Officer and Representative Director
Daiichi Sankyo Company, Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCRYST PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.